Baseline elevated leukocyte count in peripheral blood is associated with poor survival in patients with advanced non-small cell lung cancer: a prognostic model

By Tibaldi C.  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 10, 2008-10 ,pp. : 1143-1149

Springer Publishing Company

Access to resources Recommend Favorite

Expression of RRM1 and RRM2 as a novel prognostic marker in advanced non-small cell lung cancer receiving chemotherapy

By Wang Lei   Meng Long   Wang Xing-wen   Ma Guo-yuan   Chen Jing-han  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 1899-1906

Springer Publishing Company

Access to resources Recommend Favorite

High expression of M3 muscarinic acetylcholine receptor is a novel biomarker of poor prognostic in patients with non-small cell lung cancer

By Wu Jun   Zhou Jinxu   Yao Lei   Lang Yaoguo   Liang Yingnan   Chen Lantao   Zhang Jinfeng   Wang Fengjiao   Wang Yanbo   Chen He   Ma Jianqun  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3939-3944

Springer Publishing Company

Access to resources Recommend Favorite

Neuroepithelial transforming gene 1 functions as a potential prognostic marker for patients with non-small cell lung cancer

By            

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 7439-7446

Spandidos Publications

Access to resources Recommend Favorite

Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib

By                              

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 802-806

Science Publishers

Access to resources Recommend Favorite